Cash burn at Alphabet, Amazon.com ( AMZN) and Meta Platforms ( META) is raising more questions about the payback on huge ...
According to FactSet, Wall Street expects Marriott earnings to increase 17.3% in 2026 and another 11.5% in 2027. That would ...
Investor's Business Daily on MSN
These IBD 50 energy stocks show gigantic earnings growth
Energy-related stocks now dominate the IBD 50, along with technology. The energy sector is up more than 11% this month, ...
Investor's Business Daily on MSN
eBay, IBD stock of the day, keeps momentum with earnings beat
eBay stock is hovering near an entry after getting a strong response to its Q3 results, adding to a recent rally.
Investor's Business Daily on MSN
Palantir Earnings Top Views. Revenue Beat Slightly Smaller.
Palantir stock climbed amid Q3 earnings and revenue that topped consensus estimates. Sales growth accelerated for the 13th straight quarter.
Newer therapies must sustain double-digit growth to offset the impact of Humira's patent cliff, a test that shapes the ...
Palisade Bio's phase 2b ASCENTRA-UC trial for ulcerative colitis has begun dosing, with 12-week topline results expected in Q4 2027. I rate PALI stock as Buy.
Many of today’s most serious diseases look different on the surface, but growing evidence suggests they share a common driver: chronic inflammation. This November, Sinai Health Foundation is bringing ...
Appointments strengthen executive leadership team as Caldera prepares for its transition to a publicly traded company and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results